News and Updates

Earlier this week, Beta Bionics announced that the Food and Drug Administration (FDA) has granted breakthrough device designation to the company’s iLet Bionic Pancreas System, a wearable pocket-sized device used for blood sugar control in people with diabetes. The device can be adjusted to work as an insulin-only, glucagon-only or bi-hormonal artificial pancreas using both […]

There’s 11 days left in 2019, but what did Breakthrough T1D see this year that said “breakthrough”? This top 10 list reflects advances in type 1 diabetes (T1D) research, with many funded by Breakthrough T1D or the Breakthrough T1D T1D Fund. Other type 1 diabetes research breakthroughs in 2019 were advanced by the National Institutes […]

It’s a devastating statistic: More than 90% of people with type 1 diabetes (T1D) develop diabetic eye disease within 20 years of diagnosis. But thanks to Jennifer Sun, M.D., M.P.H., of Joslin Diabetes Center in Boston, we’re making headway in the fight to prevent eye disease altogether. She is finding ways to diagnose eye disease […]

The Food and Drug Administration (FDA) today authorized an algorithm that enables the second artificial pancreas system: The Control-IQ™ advanced hybrid closed loop technology. For now, the algorithm can be used with Tandem’s t:slim X2™ insulin pump and Dexcom’s G6 continuous glucose monitor (CGM). Though this is not the first algorithm approved for an artificial […]

Breakthrough T1D is incredibly proud of Glen Tullman, Breakthrough T1D Director Emeritus and a committed member of the Breakthrough T1D Illinois Chapter for receiving the Robert F. Kennedy Human Rights Ripple of Hope Award. This prestigious award recognizes and honors leaders of the international business, entertainment, and activist communities who have demonstrated a commitment to […]

It’s a devastating statistic: 1 in 4 people with type 1 diabetes (T1D) are affected by kidney disease. But thanks to Monika Niewczas, M.D., Ph.D., M.P.H., and Manoj Gupta, Ph.D., of Joslin Diabetes Center in Boston, we’re making headway in the fight to prevent kidney disease altogether. They are finding ways to diagnose kidney disease […]

On Sunday, December 8—also known as Week  14 for NFL fans—the NFL’s My Cause, My Cleats campaign returned for the fourth consecutive season. This campaign allows players to express their commitment and promote the causes that are most important to them. Throughout the campaign, players represent hundreds of charitable organizations that focus on causes such […]

As the leading global funder of type 1 diabetes (T1D) research, Breakthrough T1D invests in the most promising research studies across the world—including more than 70 clinical trials happening right now—to help improve the lives of people with T1D and find cures. That’s a big deal! Let’s take a look at three of them: A […]

Breakthrough T1D is funding work to build a better insulin infusion set; the current infusion sets can be uncomfortable and unreliable, and need to be changed every two to three days. One partner is Pacific Diabetes Technologies, who will test its all-in-one continuous glucose monitoring (CGM) sensor and infusion set in people with type 1 […]

Reza Abdi, M.D., has a reason to care about type 1 diabetes research—he has a father and a brother with the disease. Dr. Abdi, of Brigham and Women’s Hospital in Boston, is an expert in immune therapy research, specifically nanotechnologies—miniscule therapies that can deliver immune treatments to specific regions in the body. His goal: To […]